| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in AV node cell action potential | 6.56e-05 | 3 | 94 | 2 | GO:0086056 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1C NIPAL4 TRPC4AP SLC12A9 MCU KCNJ12 CACNA1G KCNJ18 ASIC3 PKD1L3 | 6.71e-05 | 465 | 94 | 10 | GO:0046873 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 2.16e-04 | 343 | 94 | 8 | GO:0005261 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 2.17e-04 | 5 | 94 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 2.17e-04 | 5 | 94 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | calcium channel activity | 3.61e-04 | 129 | 94 | 5 | GO:0005262 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1C NIPAL4 TRPC4AP SLC12A9 MCU KCNJ12 CACNA1G KCNJ18 ASIC3 PKD1L3 | 7.33e-04 | 627 | 94 | 10 | GO:0022890 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 7.40e-04 | 151 | 94 | 5 | GO:0015085 | |
| GeneOntologyBiologicalProcess | cell-cell signaling involved in lung development | 2.01e-05 | 2 | 93 | 2 | GO:0060495 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | SPTBN5 CACNA1C KAT2B SEMA7A SLC12A9 MYO5B CACNA1G EXT1 ACTN2 SERPINF2 KLK1 VASP | 2.14e-05 | 618 | 93 | 12 | GO:0090066 |
| GeneOntologyCellularComponent | filopodium | 1.96e-05 | 123 | 94 | 6 | GO:0030175 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 5.17e-05 | 378 | 94 | 9 | GO:0034702 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | CACNA1C ABCA2 OLFM3 MCU KCNJ12 LRRTM4 CACNA1G OLFM2 KCNJ18 PKD1L3 | 1.21e-04 | 523 | 94 | 10 | GO:1902495 |
| GeneOntologyCellularComponent | transporter complex | CACNA1C ABCA2 OLFM3 MCU KCNJ12 LRRTM4 CACNA1G OLFM2 KCNJ18 PKD1L3 | 1.83e-04 | 550 | 94 | 10 | GO:1990351 |
| GeneOntologyCellularComponent | actin-based cell projection | 2.61e-04 | 278 | 94 | 7 | GO:0098858 | |
| GeneOntologyCellularComponent | AMPA glutamate receptor complex | 3.27e-04 | 30 | 94 | 3 | GO:0032281 | |
| GeneOntologyCellularComponent | Derlin-1 retrotranslocation complex | 5.50e-04 | 8 | 94 | 2 | GO:0036513 | |
| GeneOntologyCellularComponent | apical cortex | 8.79e-04 | 10 | 94 | 2 | GO:0045179 | |
| GeneOntologyCellularComponent | membrane protein complex | SEL1L CACNA1C ABCA2 OLFM3 VPS39 SYNE1 MCU KCNJ12 SYNE2 LRRTM4 CACNA1G IRS1 OLFM2 KCNJ18 HM13 PKD1L3 | 9.93e-04 | 1498 | 94 | 16 | GO:0098796 |
| GeneOntologyCellularComponent | microtubule organizing center attachment site | 1.07e-03 | 11 | 94 | 2 | GO:0034992 | |
| GeneOntologyCellularComponent | meiotic nuclear membrane microtubule tethering complex | 1.07e-03 | 11 | 94 | 2 | GO:0034993 | |
| GeneOntologyCellularComponent | nuclear membrane protein complex | 1.07e-03 | 11 | 94 | 2 | GO:0106083 | |
| GeneOntologyCellularComponent | nuclear membrane microtubule tethering complex | 1.07e-03 | 11 | 94 | 2 | GO:0106094 | |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 1.09e-03 | 45 | 94 | 3 | GO:0008328 | |
| GeneOntologyCellularComponent | myofibril | 1.46e-03 | 273 | 94 | 6 | GO:0030016 | |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 1.48e-03 | 50 | 94 | 3 | GO:0098878 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.99e-03 | 290 | 94 | 6 | GO:0043292 | |
| Domain | Actinin_actin-bd_CS | 8.61e-08 | 23 | 93 | 5 | IPR001589 | |
| Domain | ACTININ_2 | 8.61e-08 | 23 | 93 | 5 | PS00020 | |
| Domain | ACTININ_1 | 8.61e-08 | 23 | 93 | 5 | PS00019 | |
| Domain | CH | 1.31e-06 | 70 | 93 | 6 | PF00307 | |
| Domain | - | 1.43e-06 | 71 | 93 | 6 | 1.10.418.10 | |
| Domain | CH | 1.69e-06 | 73 | 93 | 6 | PS50021 | |
| Domain | CH-domain | 1.98e-06 | 75 | 93 | 6 | IPR001715 | |
| Domain | Spectrin | 4.74e-06 | 23 | 93 | 4 | PF00435 | |
| Domain | Spectrin_repeat | 1.24e-05 | 29 | 93 | 4 | IPR002017 | |
| Domain | CH | 1.79e-05 | 65 | 93 | 5 | SM00033 | |
| Domain | Spectrin/alpha-actinin | 1.86e-05 | 32 | 93 | 4 | IPR018159 | |
| Domain | SPEC | 1.86e-05 | 32 | 93 | 4 | SM00150 | |
| Domain | K_chnl_inward-rec_Kir2.2 | 2.45e-05 | 2 | 93 | 2 | IPR003272 | |
| Domain | K_chnl_inward-rec_Kir_N | 7.33e-05 | 3 | 93 | 2 | IPR013673 | |
| Domain | VASP_tetra | 7.33e-05 | 3 | 93 | 2 | IPR014885 | |
| Domain | IRK_N | 7.33e-05 | 3 | 93 | 2 | PF08466 | |
| Domain | VASP_tetra | 7.33e-05 | 3 | 93 | 2 | PF08776 | |
| Domain | Cse1 | 7.33e-05 | 3 | 93 | 2 | IPR013713 | |
| Domain | Noelin-1 | 7.33e-05 | 3 | 93 | 2 | PF12308 | |
| Domain | Noelin_dom | 7.33e-05 | 3 | 93 | 2 | IPR022082 | |
| Domain | Cse1 | 7.33e-05 | 3 | 93 | 2 | PF08506 | |
| Domain | KASH | 1.46e-04 | 4 | 93 | 2 | PF10541 | |
| Domain | KASH | 1.46e-04 | 4 | 93 | 2 | IPR012315 | |
| Domain | KASH | 1.46e-04 | 4 | 93 | 2 | PS51049 | |
| Domain | KASH | 1.46e-04 | 4 | 93 | 2 | SM01249 | |
| Domain | Sel1 | 6.74e-04 | 8 | 93 | 2 | PF08238 | |
| Domain | SEL1 | 6.74e-04 | 8 | 93 | 2 | SM00671 | |
| Domain | Sel1-like | 8.63e-04 | 9 | 93 | 2 | IPR006597 | |
| Domain | VDCCAlpha1 | 1.08e-03 | 10 | 93 | 2 | IPR002077 | |
| Domain | WH1 | 1.31e-03 | 11 | 93 | 2 | SM00461 | |
| Domain | WH1/EVH1_dom | 1.31e-03 | 11 | 93 | 2 | IPR000697 | |
| Domain | WH1 | 1.31e-03 | 11 | 93 | 2 | PF00568 | |
| Domain | TF_fork_head_CS_2 | 1.55e-03 | 46 | 93 | 3 | IPR030456 | |
| Domain | TF_fork_head_CS_1 | 1.65e-03 | 47 | 93 | 3 | IPR018122 | |
| Domain | OLF | 1.85e-03 | 13 | 93 | 2 | PS51132 | |
| Domain | WH1 | 1.85e-03 | 13 | 93 | 2 | PS50229 | |
| Domain | Olfac-like_dom | 1.85e-03 | 13 | 93 | 2 | IPR003112 | |
| Domain | OLF | 1.85e-03 | 13 | 93 | 2 | SM00284 | |
| Domain | OLF | 1.85e-03 | 13 | 93 | 2 | PF02191 | |
| Domain | FH | 1.87e-03 | 49 | 93 | 3 | SM00339 | |
| Domain | FORK_HEAD_1 | 1.87e-03 | 49 | 93 | 3 | PS00657 | |
| Domain | FORK_HEAD_2 | 1.87e-03 | 49 | 93 | 3 | PS00658 | |
| Domain | Fork_head_dom | 1.87e-03 | 49 | 93 | 3 | IPR001766 | |
| Domain | FORK_HEAD_3 | 1.87e-03 | 49 | 93 | 3 | PS50039 | |
| Domain | Forkhead | 1.87e-03 | 49 | 93 | 3 | PF00250 | |
| Domain | IMPORTIN_B_NT | 2.15e-03 | 14 | 93 | 2 | PS50166 | |
| Domain | Ldl_recept_b | 2.15e-03 | 14 | 93 | 2 | PF00058 | |
| Domain | LDLRB | 2.15e-03 | 14 | 93 | 2 | PS51120 | |
| Domain | IBN_N | 2.47e-03 | 15 | 93 | 2 | PF03810 | |
| Domain | LY | 2.47e-03 | 15 | 93 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 2.47e-03 | 15 | 93 | 2 | IPR000033 | |
| Domain | K_chnl_inward-rec_Kir_cyto | 2.81e-03 | 16 | 93 | 2 | IPR013518 | |
| Domain | IBN_N | 2.81e-03 | 16 | 93 | 2 | SM00913 | |
| Domain | IRK | 2.81e-03 | 16 | 93 | 2 | PF01007 | |
| Domain | - | 2.81e-03 | 16 | 93 | 2 | 2.60.40.1400 | |
| Domain | K_chnl_inward-rec_Kir | 2.81e-03 | 16 | 93 | 2 | IPR016449 | |
| Domain | Importin-beta_N | 3.18e-03 | 17 | 93 | 2 | IPR001494 | |
| Domain | EGF_CA | 3.23e-03 | 122 | 93 | 4 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 3.43e-03 | 124 | 93 | 4 | IPR001881 | |
| Domain | EGF | 3.63e-03 | 126 | 93 | 4 | PF00008 | |
| Pubmed | SEL1L TRPC4AP IPO8 IPO7 VPS39 SYNE1 SYNE2 ZFR CACNA1G C1orf167 PRPF8 PLRG1 | 1.17e-06 | 754 | 96 | 12 | 35906200 | |
| Pubmed | Mammalian Fat1 cadherin regulates actin dynamics and cell-cell contact. | 1.69e-06 | 9 | 96 | 3 | 15148305 | |
| Pubmed | 3.16e-06 | 225 | 96 | 7 | 12168954 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 22768332 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 11792814 | ||
| Pubmed | Nesprin-1 and nesprin-2 regulate endothelial cell shape and migration. | 7.54e-06 | 2 | 96 | 2 | 24931616 | |
| Pubmed | Syne-1 and Syne-2 play crucial roles in myonuclear anchorage and motor neuron innervation. | 7.54e-06 | 2 | 96 | 2 | 17267447 | |
| Pubmed | Nesprins: tissue-specific expression of epsilon and other short isoforms. | 7.54e-06 | 2 | 96 | 2 | 24718612 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 24586179 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 36959177 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 17761684 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 31578382 | ||
| Pubmed | Role of Kir2.2 in hypercapnic ventilatory response during postnatal development of mouse. | 7.54e-06 | 2 | 96 | 2 | 15705530 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 11810195 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 12940993 | ||
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 20009030 | ||
| Pubmed | The inositol phosphatase MTMR4 is a novel target of the ubiquitin ligase Nedd4. | 7.54e-06 | 2 | 96 | 2 | 19125695 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 21220429 | ||
| Pubmed | Association of CACNA1C and SYNE1 in offspring of patients with psychiatric disorders. | 7.54e-06 | 2 | 96 | 2 | 27620326 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 12933343 | ||
| Pubmed | Calcium handling precedes cardiac differentiation to initiate the first heartbeat. | 1.35e-05 | 17 | 96 | 3 | 27725084 | |
| Pubmed | USP31 CACTIN URB1 IPO8 DNAJC10 IPO7 N4BP2 SYNE1 SYNE2 CHD1 VARS2 HM13 PRPF8 PLRG1 VPS13B | 1.37e-05 | 1487 | 96 | 15 | 33957083 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | SEL1L TRPC4AP MTMR4 FOXK2 IPO8 DNAJC10 IPO7 PKP3 CHD1 LCP1 PRPF8 FN3K | 1.57e-05 | 974 | 96 | 12 | 28675297 |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 17640933 | ||
| Pubmed | An siRNA screen identifies RSK1 as a key modulator of lung cancer metastasis. | 2.26e-05 | 3 | 96 | 2 | 21423205 | |
| Pubmed | A Requirement for Mena, an Actin Regulator, in Local mRNA Translation in Developing Neurons. | 2.26e-05 | 3 | 96 | 2 | 28735747 | |
| Pubmed | VASP is a CXCR2-interacting protein that regulates CXCR2-mediated polarization and chemotaxis. | 2.26e-05 | 3 | 96 | 2 | 19435808 | |
| Pubmed | Cell autonomous defects in cortical development revealed by two-color chimera analysis. | 2.26e-05 | 3 | 96 | 2 | 19386231 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 10878022 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 21228389 | ||
| Pubmed | Comparative genomics and diversifying selection of the clustered vertebrate protocadherin genes. | 2.26e-05 | 3 | 96 | 2 | 15744052 | |
| Pubmed | Decreased cardiac L-type Ca²⁺ channel activity induces hypertrophy and heart failure in mice. | 2.26e-05 | 3 | 96 | 2 | 22133878 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 23937664 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 10801818 | ||
| Pubmed | The inner nuclear membrane protein Sun1 mediates the anchorage of Nesprin-2 to the nuclear envelope. | 2.26e-05 | 3 | 96 | 2 | 16079285 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 12408964 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 8083233 | ||
| Pubmed | Preferential utilization of Imp7/8 in nuclear import of Smads. | 2.26e-05 | 3 | 96 | 2 | 18519565 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 11410627 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 17462627 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 10904001 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 31919478 | ||
| Pubmed | Identification of novel interacting partners of the NEDD4 ubiquitin ligase in mouse testis. | 2.26e-05 | 3 | 96 | 2 | 32450490 | |
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 37739992 | ||
| Pubmed | 2.26e-05 | 3 | 96 | 2 | 33472039 | ||
| Pubmed | Nesprins anchor kinesin-1 motors to the nucleus to drive nuclear distribution in muscle cells. | 2.26e-05 | 3 | 96 | 2 | 25516977 | |
| Pubmed | 3.95e-05 | 24 | 96 | 3 | 22632720 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | SEL1L FAT1 DNAJC10 SEMA7A ARSK VWA5A MCU ENAH EXT1 IRS1 VARS2 PRPF8 CTSB NEDD4 | 4.43e-05 | 1451 | 96 | 14 | 30550785 |
| Pubmed | 4.49e-05 | 25 | 96 | 3 | 38877142 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 8921409 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 16648470 | ||
| Pubmed | Lamellipodin, an Ena/VASP ligand, is implicated in the regulation of lamellipodial dynamics. | 4.51e-05 | 4 | 96 | 2 | 15469845 | |
| Pubmed | Ena/VASP is required for endothelial barrier function in vivo. | 4.51e-05 | 4 | 96 | 2 | 17998398 | |
| Pubmed | LINC complexes mediate the positioning of cone photoreceptor nuclei in mouse retina. | 4.51e-05 | 4 | 96 | 2 | 23071752 | |
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 21398369 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 24434121 | ||
| Pubmed | Mena binds α5 integrin directly and modulates α5β1 function. | 4.51e-05 | 4 | 96 | 2 | 22908313 | |
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 16979624 | ||
| Pubmed | Molecular coupling of a Ca2+-activated K+ channel to L-type Ca2+ channels via alpha-actinin2. | 4.51e-05 | 4 | 96 | 2 | 17110593 | |
| Pubmed | Nesprins, but not sun proteins, switch isoforms at the nuclear envelope during muscle development. | 4.51e-05 | 4 | 96 | 2 | 20108321 | |
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 18317468 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 20798526 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 32990585 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 15371503 | ||
| Pubmed | Characterization of early EDEM1 protein maturation events and their functional implications. | 4.51e-05 | 4 | 96 | 2 | 21632540 | |
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 19596800 | ||
| Pubmed | Functional importance of L- and P/Q-type voltage-gated calcium channels in human renal vasculature. | 4.51e-05 | 4 | 96 | 2 | 21788606 | |
| Pubmed | The ERdj5-Sel1L complex facilitates cholera toxin retrotranslocation. | 4.51e-05 | 4 | 96 | 2 | 23363602 | |
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 9368023 | ||
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 10069337 | ||
| Pubmed | Outer nuclear membrane protein Kuduk modulates the LINC complex and nuclear envelope architecture. | 4.51e-05 | 4 | 96 | 2 | 28716842 | |
| Pubmed | Proteomic analysis identifies novel binding partners of BAP1. | 7.34e-05 | 80 | 96 | 4 | 34591877 | |
| Pubmed | PREL1 provides a link from Ras signalling to the actin cytoskeleton via Ena/VASP proteins. | 7.50e-05 | 5 | 96 | 2 | 15642358 | |
| Pubmed | 7.50e-05 | 5 | 96 | 2 | 16631741 | ||
| Pubmed | 7.50e-05 | 5 | 96 | 2 | 9214382 | ||
| Pubmed | 7.50e-05 | 5 | 96 | 2 | 16177047 | ||
| Pubmed | 7.50e-05 | 5 | 96 | 2 | 18396275 | ||
| Pubmed | LINC complexes form by binding of three KASH peptides to domain interfaces of trimeric SUN proteins. | 7.50e-05 | 5 | 96 | 2 | 22632968 | |
| Pubmed | A luminal flavoprotein in endoplasmic reticulum-associated degradation. | 7.50e-05 | 5 | 96 | 2 | 19706418 | |
| Pubmed | 7.50e-05 | 5 | 96 | 2 | 16376568 | ||
| Pubmed | 7.50e-05 | 5 | 96 | 2 | 11717310 | ||
| Pubmed | A requirement for filopodia extension toward Slit during Robo-mediated axon repulsion. | 7.50e-05 | 5 | 96 | 2 | 27091449 | |
| Pubmed | 7.50e-05 | 5 | 96 | 2 | 16336193 | ||
| Pubmed | 8.33e-05 | 653 | 96 | 9 | 22586326 | ||
| Pubmed | Tbx3 controls the sinoatrial node gene program and imposes pacemaker function on the atria. | 8.66e-05 | 31 | 96 | 3 | 17473172 | |
| Pubmed | 9.48e-05 | 164 | 96 | 5 | 32409323 | ||
| Pubmed | Lem2 is essential for cardiac development by maintaining nuclear integrity. | 9.54e-05 | 32 | 96 | 3 | 37067297 | |
| Pubmed | 1.12e-04 | 6 | 96 | 2 | 37591201 | ||
| Pubmed | 1.12e-04 | 6 | 96 | 2 | 19812697 | ||
| Pubmed | 1.12e-04 | 6 | 96 | 2 | 9529344 | ||
| Pubmed | 1.12e-04 | 6 | 96 | 2 | 7580148 | ||
| Pubmed | Endophilin, Lamellipodin, and Mena cooperate to regulate F-actin-dependent EGF-receptor endocytosis. | 1.12e-04 | 6 | 96 | 2 | 24076656 | |
| Pubmed | Mouse profilin 2 regulates endocytosis and competes with SH3 ligand binding to dynamin 1. | 1.12e-04 | 6 | 96 | 2 | 16319076 | |
| Pubmed | TES is a novel focal adhesion protein with a role in cell spreading. | 1.12e-04 | 6 | 96 | 2 | 12571287 | |
| Pubmed | The E3 Ubiquitin Ligase TRIM9 Is a Filopodia Off Switch Required for Netrin-Dependent Axon Guidance. | 1.12e-04 | 6 | 96 | 2 | 26702829 | |
| Pubmed | Structural Analysis of Different LINC Complexes Reveals Distinct Binding Modes. | 1.12e-04 | 6 | 96 | 2 | 33058875 | |
| Pubmed | 1.12e-04 | 6 | 96 | 2 | 18827015 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | FAT1 CUX2 SLC12A9 MYO5B LRP2 LCP1 PKD1L3 KLK1 MVP VASP STRIP1 | 1.15e-04 | 1016 | 96 | 11 | 19056867 |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | SEL1L IPO8 DNAJC10 IPO7 MCU CHD1 IRS1 HM13 PRPF8 PLRG1 STRIP1 TBC1D24 | 1.19e-04 | 1203 | 96 | 12 | 29180619 |
| Pubmed | Identification of type 2 diabetes-associated combination of SNPs using support vector machine. | 1.21e-04 | 91 | 96 | 4 | 20416077 | |
| GeneFamily | ENAH/VASPs | 3.13e-05 | 3 | 59 | 2 | 946 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 6.26e-05 | 4 | 59 | 2 | 1252 | |
| GeneFamily | Low density lipoprotein receptors | 7.98e-04 | 13 | 59 | 2 | 634 | |
| GeneFamily | Potassium voltage-gated channel subfamily J | 1.22e-03 | 16 | 59 | 2 | 276 | |
| GeneFamily | Cadherin related | 1.38e-03 | 17 | 59 | 2 | 24 | |
| GeneFamily | Armadillo repeat containing|Importins | 1.55e-03 | 18 | 59 | 2 | 596 | |
| GeneFamily | NLR family | 2.99e-03 | 25 | 59 | 2 | 666 | |
| GeneFamily | Calcium voltage-gated channel subunits | 3.24e-03 | 26 | 59 | 2 | 253 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.22e-07 | 195 | 96 | 7 | 1e28617ca55e5f318a228357737b968dfac8cca0 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.63e-07 | 200 | 96 | 7 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Papillary_Renal_Cell_Carcinoma-8|TCGA-Kidney / Sample_Type by Project: Shred V9 | 2.51e-06 | 179 | 96 | 6 | 8c6a84602b079bd357c66244371eb23dd9384918 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.59e-06 | 180 | 96 | 6 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.59e-06 | 180 | 96 | 6 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | tumor_Lung-Myeloid_cells-CD207+CD1a+_LCs|tumor_Lung / Location, Cell class and cell subclass | 2.77e-06 | 182 | 96 | 6 | 243779ba1009097f8fafa1a691e296ec3aeefc04 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-06 | 184 | 96 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-06 | 184 | 96 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-06 | 184 | 96 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-05 | 152 | 96 | 5 | bfc7ef4ee26165d18ac4f475a9519e8d52453ba2 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 160 | 96 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-05 | 160 | 96 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Excitatory_Neuron.Slc17a7.Cbln4_(Neuron.Slc17a7.Cbln4)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.59e-05 | 79 | 96 | 4 | d24301b6694f64e8bb1b5f0673f653d25d45d3eb | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Excitatory_Neuron.Slc17a7.Cbln4_(Neuron.Slc17a7.Cbln4)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.59e-05 | 79 | 96 | 4 | 397f3a1f5fa67dd0b2ed53ebcad74dedf0498fce | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.09e-05 | 167 | 96 | 5 | c042d6cdddd0e1ddef1e3ac6f4fe23151127b0f2 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.09e-05 | 167 | 96 | 5 | 351f8de1fbdf742ac74f9099b254d515ab539bb2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.36e-05 | 170 | 96 | 5 | 3174ea9cf93892a8b41de10fd4ff6f06bb41502d | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9|TCGA-Bladder / Sample_Type by Project: Shred V9 | 3.46e-05 | 171 | 96 | 5 | adbcfa4bf6bc1c604535a24435924cdb091e2dd7 | |
| ToppCell | mild-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.46e-05 | 171 | 96 | 5 | 5c8198182495bda7a826e9d80aa467f4eb1094ec | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 3.86e-05 | 175 | 96 | 5 | 0cc215109d9915af47e4d0a120ce2e46910715fa | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD207+CD1a+_LCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 4.41e-05 | 180 | 96 | 5 | 289f8c4b53ffd164fee1f459a9315c0deb5f76d0 | |
| ToppCell | severe-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.41e-05 | 180 | 96 | 5 | ac03812b1409435c55d323a7516deeac82bd3509 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.53e-05 | 181 | 96 | 5 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.53e-05 | 181 | 96 | 5 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.53e-05 | 181 | 96 | 5 | 12ff56fa2949c8d53360cdf2cacfd326e65b54aa | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.03e-05 | 185 | 96 | 5 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.16e-05 | 186 | 96 | 5 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | COVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.29e-05 | 187 | 96 | 5 | d23aae9419d460b78b1d4092d7acd9108a47cfbe | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.29e-05 | 187 | 96 | 5 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.43e-05 | 188 | 96 | 5 | 50c1b1d690f0e9443082f2adf4f1b8e9ce4cd337 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 5.56e-05 | 189 | 96 | 5 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 5.70e-05 | 190 | 96 | 5 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-05 | 191 | 96 | 5 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.85e-05 | 191 | 96 | 5 | 7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-05 | 191 | 96 | 5 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-05 | 191 | 96 | 5 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 5.99e-05 | 192 | 96 | 5 | f18da8db573e584c8b90df0814afcf020360108e | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 5.99e-05 | 192 | 96 | 5 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.14e-05 | 193 | 96 | 5 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.30e-05 | 194 | 96 | 5 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.30e-05 | 194 | 96 | 5 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 6.45e-05 | 195 | 96 | 5 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 6.45e-05 | 195 | 96 | 5 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.61e-05 | 196 | 96 | 5 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 6.61e-05 | 196 | 96 | 5 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 6.61e-05 | 196 | 96 | 5 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | LPS_only-Hematopoietic_Myeloid-Dendritic_cells|LPS_only / Treatment groups by lineage, cell group, cell type | 6.77e-05 | 197 | 96 | 5 | 59ddd8ff7dddf3747b988374e1a4d80959db803e | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 6.93e-05 | 198 | 96 | 5 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 7.10e-05 | 199 | 96 | 5 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.27e-05 | 200 | 96 | 5 | 12326cc6f0af24bacba9493dc79e7c7347db2f41 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 7.27e-05 | 200 | 96 | 5 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Mast_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.27e-05 | 200 | 96 | 5 | c3511607692e05f44538a376253673dd18f77908 | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.27e-05 | 200 | 96 | 5 | 362706445edb33b313684efe50b1f44f5f816e67 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 7.27e-05 | 200 | 96 | 5 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Mast_cell-Mast_cell|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.27e-05 | 200 | 96 | 5 | 1c58860932ed47263a5a537a64f0343201463c21 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.27e-05 | 200 | 96 | 5 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 6.26e-05 | 4 | 96 | 2 | cv:CN293514 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 1.04e-04 | 5 | 96 | 2 | C1450051 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 1.04e-04 | 5 | 96 | 2 | C0410190 | |
| Disease | Emery-Dreifuss muscular dystrophy | 1.56e-04 | 6 | 96 | 2 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 1.56e-04 | 6 | 96 | 2 | C0410189 | |
| Disease | progressive familial intrahepatic cholestasis (is_implicated_in) | 2.18e-04 | 7 | 96 | 2 | DOID:0070221 (is_implicated_in) | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 2.18e-04 | 7 | 96 | 2 | C0751337 | |
| Disease | memory performance | 3.86e-04 | 409 | 96 | 7 | EFO_0004874 | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 4.29e-04 | 45 | 96 | 3 | EFO_0004623, EFO_0004791 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 4.29e-04 | 45 | 96 | 3 | EFO_0004623, EFO_0004792 | |
| Disease | tauopathy (implicated_via_orthology) | 4.63e-04 | 10 | 96 | 2 | DOID:680 (implicated_via_orthology) | |
| Disease | pneumonia, COVID-19 | 5.16e-04 | 113 | 96 | 4 | EFO_0003106, MONDO_0100096 | |
| Disease | reticulocyte count | KAT2B FAT1 FOXK2 NUDT14 KCNJ12 SYNE2 HECTD4 ZBTB40 IRS1 LCP1 PRPF8 | 5.90e-04 | 1045 | 96 | 11 | EFO_0007986 |
| Disease | sleep quality | 6.08e-04 | 118 | 96 | 4 | EFO_0005272 | |
| Disease | reticulocyte measurement | KAT2B FAT1 FOXK2 NUDT14 KCNJ12 SYNE2 HECTD4 ZBTB40 IRS1 LCP1 PRPF8 | 6.28e-04 | 1053 | 96 | 11 | EFO_0010700 |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 6.77e-04 | 12 | 96 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | alcohol consumption measurement, alcohol drinking | 6.77e-04 | 12 | 96 | 2 | EFO_0004329, EFO_0007878 | |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 8.16e-04 | 56 | 96 | 3 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | Prostatic Neoplasms | 9.13e-04 | 616 | 96 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 9.13e-04 | 616 | 96 | 8 | C0376358 | |
| Disease | 3-hydroxypropylmercapturic acid measurement | 1.04e-03 | 352 | 96 | 6 | EFO_0007014 | |
| Disease | susceptibility to hepatitis B infection measurement | 1.20e-03 | 64 | 96 | 3 | EFO_0008405 | |
| Disease | retinal vasculature measurement | 1.52e-03 | 517 | 96 | 7 | EFO_0010554 | |
| Disease | esterified cholesterol measurement, high density lipoprotein cholesterol measurement | 1.73e-03 | 19 | 96 | 2 | EFO_0004612, EFO_0008589 | |
| Disease | facial attractiveness measurement | 1.73e-03 | 19 | 96 | 2 | EFO_0009892 | |
| Disease | cystatin C measurement | 2.04e-03 | 402 | 96 | 6 | EFO_0004617 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 2.15e-03 | 166 | 96 | 4 | EFO_0004530, EFO_0004611 | |
| Disease | nephrosis (biomarker_via_orthology) | 2.32e-03 | 22 | 96 | 2 | DOID:2527 (biomarker_via_orthology) | |
| Disease | neuroticism measurement, cognitive function measurement | 2.52e-03 | 566 | 96 | 7 | EFO_0007660, EFO_0008354 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IHKYGNAARNDLWNT | 556 | Q9UKU6 | |
| GQNYSNVIANLRWHQ | 496 | Q6UWY0 | |
| AQQFQGTARWYQHTR | 891 | Q5SNV9 | |
| APYRNVNIQNFHTSW | 166 | P35609 | |
| KRNTTWQAGHNFYNV | 36 | P07858 | |
| LLNAIHFQGFWRNKF | 231 | P08697 | |
| LQAANSYLRDQWFHS | 141 | Q8IY22 | |
| NLKTNTVINWFHNYR | 1206 | O14529 | |
| LRDYQLNGLNWLAHS | 481 | O14646 | |
| TWNNGHQVLYNVTLF | 431 | O95897 | |
| YLRGVNNARQPWHNA | 286 | Q68EN5 | |
| WHAVALEVNGNYARL | 3911 | Q14517 | |
| FYQRSKAGWQNSIRH | 181 | A8MTJ6 | |
| LQVHYWASFAQQRGI | 1331 | Q14667 | |
| NNLYWTNDGHRKTIN | 611 | Q9NZR2 | |
| VHQRIASWQNLGAVY | 51 | Q8NE86 | |
| QARSSYLANEILWGH | 311 | Q14500 | |
| CISDNYQLWLGRHNL | 66 | P06870 | |
| YQLWLGRHNLFDDEN | 71 | P06870 | |
| HYFRGINNLQQPWNS | 336 | Q8NCT3 | |
| FAGLNQLIWLYLDHN | 81 | Q86VH4 | |
| GRIFYINHNIKRTQW | 906 | P46934 | |
| HLQWNFIQAGAAQAL | 896 | Q7RTR2 | |
| FLNRINYWHLEAPSQ | 251 | Q92831 | |
| LTLHYRQNGAQKSWD | 21 | O95848 | |
| GWQNSIRHNLSLNRY | 301 | Q01167 | |
| NWVSNYNALRAAAGI | 261 | Q8WVQ1 | |
| LRWANYHLENAGCNK | 271 | P13796 | |
| WRTGYNFQRVHAAVQ | 441 | O43660 | |
| NWMEYLHGFNLSLQA | 321 | Q9NYQ8 | |
| NRNPVWYQALTHGLN | 971 | O95373 | |
| HWIANNLFGLAFSLN | 181 | Q8TCT9 | |
| GNWYLANNRKHCIVD | 2681 | P98164 | |
| DKVLGYFWNRQHSQR | 466 | Q9UHC3 | |
| LQARGALYTAHAQAW | 221 | Q32M88 | |
| QELLVWYGNSHNTFL | 196 | Q9H4Q4 | |
| GLVNLRVAGNHTQWY | 116 | A1L453 | |
| NGRAVHYNGSSLLQW | 2041 | Q9Y4D8 | |
| WYQALLQLHNRAKGH | 106 | P35568 | |
| RSLTQSHIQYFQWGR | 56 | Q8N7R1 | |
| TADHARLQLQLAYNW | 531 | Q14764 | |
| RLQLQLAYNWHFEVN | 536 | Q14764 | |
| NYHWQLSFLRAEQVL | 231 | Q8N8X9 | |
| WALLRAGNKNFHNFL | 531 | Q9NYA4 | |
| NLVQEWLAKHQGARY | 251 | P10696 | |
| VQYHGNIFFWNQSRN | 1081 | A4FU69 | |
| QHEQTFRWNAYSGIL | 91 | Q9UJJ9 | |
| HPNAYLRNGWNLLDF | 186 | Q13936 | |
| NGRNHLIFNLYSGTW | 186 | Q16394 | |
| RWVRHKYNFDNLGQA | 1461 | O43497 | |
| GRLQQHLRWLQQYVA | 506 | Q9BZC7 | |
| TQNFYWELRQKGSVH | 281 | P05108 | |
| YQFWQFHKGNLQAGQ | 651 | Q96JA4 | |
| FNRVHTGFEWNKYNQ | 646 | Q8WUQ7 | |
| SFNWQHNGRQMYVAL | 166 | O15520 | |
| TFHQWRDARQVYGLN | 76 | Q8N8S7 | |
| RWLLFFHFGKNENSN | 366 | Q8IXB1 | |
| GNFNNLRFWYNLEIH | 2531 | Q6ZTR5 | |
| YNARDRALYAWNNGH | 446 | Q96PB7 | |
| RALYAWNNGHQVLFN | 451 | Q96PB7 | |
| DWNNQSLPYHSQKLR | 631 | P20273 | |
| LWLAANNGDSQSRYH | 376 | Q14154 | |
| QLERGSITLWHNLNY | 121 | Q9UKG9 | |
| NQWFYGHTSCLNLRE | 1826 | Q3ZCN5 | |
| AFNYLNQGVVHSITW | 326 | O15397 | |
| YQKRFQNLNWRSHNN | 196 | Q9NZT2 | |
| YQGWKNSVRHNLSLN | 141 | Q12947 | |
| NFARNGALSTHNWTY | 276 | Q9HA92 | |
| KAGLLYRNHQLVNWS | 266 | Q5ST30 | |
| QARSSYLANEILWGH | 311 | B7U540 | |
| LNNFHNLLRFWQQHY | 726 | Q8TEL6 | |
| WNSASQLREQYILHQ | 5556 | Q8NF91 | |
| QSLLQLWKAYSNAHG | 5381 | Q8WXH0 | |
| LHWNRAASQGYTVAR | 616 | Q9UBV2 | |
| QLFNYLNHWNHFGRE | 281 | Q9H479 | |
| SAKNSNRFYLHQAIW | 1301 | Q7Z443 | |
| QKVRHRLNDDWAYGN | 741 | Q5VSL9 | |
| FTGQLLNHIASLYNW | 266 | O60287 | |
| LNHIASLYNWNGITD | 271 | O60287 | |
| QLNNRWASFHGNLLR | 2341 | Q9NRC6 | |
| WASFHGNLLRYQQQL | 2346 | Q9NRC6 | |
| WNIALHSNVGFRNYL | 836 | Q6Q759 | |
| GEHSQNEKINRWNYI | 476 | Q96KN2 | |
| LANLWQYNKLHRDFR | 771 | Q9Y446 | |
| THQRHDGKLWNLNNY | 1456 | Q6P2Q9 | |
| KQLARQGYWAQSHAL | 36 | Q9ULP9 | |
| QNHIGSLNWGYRVAL | 256 | Q16881 | |
| WGYVSQALLFHQVRK | 501 | Q9BXP2 | |
| QEGSYFREAQHWQLL | 616 | O75326 | |
| LVQLIYHQNANGSWD | 681 | O00534 | |
| TFWANNHGRNYTVLL | 271 | Q6ZSY5 | |
| FGVLHAQALQAAWQR | 326 | Q86VD9 | |
| LAVAQNRWLHIYDNQ | 251 | O15213 | |
| ATFHSWQERIRQNYG | 41 | Q0D2K0 | |
| LRHAKWFQARANGLQ | 906 | Q96KR1 | |
| LLLQAIYQSWSHLGN | 806 | Q7Z7G8 | |
| DSNNHLYWNALGVVA | 821 | Q6PGP7 | |
| YRGNSQHDAQEFLLW | 221 | Q70CQ4 | |
| NAWANLAHVYGRLGQ | 101 | Q5TAA0 | |
| CNKAYQQLSGLWYHN | 1011 | Q9NUA8 | |
| GSNIIYVASNHFVWR | 291 | Q96JC1 | |
| KYNQATPNFHQWRDA | 71 | P50552 | |
| HWANGVLFQQRFSYV | 251 | Q86W25 | |
| RNALAKHIYAQLFGW | 401 | Q9ULV0 | |
| VKYLGEAHEWNQNRA | 486 | Q86UW6 |